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Background/Aims: The adoption of colonoscopy as a 
primary colorectal cancer (CRC) screening technique has 
been argued for in Korea, without evidence of patient prefer-
ences. This study aimed to investigate patients’ preferences 
for the primary CRC screening test for the National Cancer 
Screening Program (NCSP). Methods: Between June and 
August 2016, 414 individuals aged ≥50 years who partici-
pated in the NCSP were prospectively invited to complete a 
questionnaire regarding their preferences for the primary 
CRC screening test and the reasons for their selection. 
Results: Among the 396 respondents who completed the 
questionnaire, 124 individuals (31.3%) preferred the fecal 
immunochemical test (FIT), whereas 272 individuals (68.7%) 
preferred colonoscopy. Elderly participants preferred the FIT 
(p<0.001), whereas participants with a higher education lev-
el (p=0.030), a higher income level (p=0.009), or individuals 
with a family member (p=0.028) or acquaintance (p=0.013) 
with a history of CRC preferred colonoscopy. Only 12.9% of 
participants had a bad experience with a previous FIT; how-
ever, 39.3% of participants had a bad experience with a pre-
vious colonoscopy. Conclusions: Colonoscopy was preferred 
to FIT in a 2.2:1 ratio as the primary CRC screening test for 
the NCSP. Patients’ preference for colonoscopy should be 
considered for the NCSP in Korea. (Gut Liver 2017;11:821-
827)
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Colonoscopy; Screening; Preference 
INTRODUCTION
The incidence of colorectal cancer (CRC) has increased rap-
idly in Western and Asian countries.1 Many countries have 
started CRC screening programs; however, screening modalities 
and strategies differ among countries.2-4 In Korea, the National 
Cancer Screening Program (NCSP) provides a single annual fe-
cal immunochemical test (FIT) for adults aged ≥50 years, and 
secondary confirmatory colonoscopy for those with positive FIT 
results.5,6 The efficacy of a FIT-based screening program may 
ultimately depend on FIT and colonoscopy participation rates. 
However, the CRC screening rate in Korea7 has remained lower 
than those for other cancers, similar to other countries.8,9 Several 
Western countries such as Australia, Germany, Poland, Swit-
zerland, and the United States use colonoscopy as a primary 
CRC screening test.7 Therefore, the adoption of colonoscopy as 
a primary CRC screening method has been argued in Korea, but 
without evidence of patient preferences.
Information about CRC screening preferences will be used 
to plan a primary colonoscopy screening strategy as well as 
to identify deficits in the current colonoscopic resources in the 
NCSP. However, some studies have reported variations in pa-
tient preferences for FIT10-14 and colonoscopy12-18 as a primary 
CRC screening test. Information about CRC screening preference 
is essential for checking the availability of national resources to 
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deliver a primary screening program. Until now, however, no 
data have been available about patient CRC screening method 
preferences under the NCSP in Korea. Here we conducted a sur-
vey to assess patient preferences about CRC screening methods 
in the NCSP. 
MATERIALS AND METHODS
1. Patients
Between June and August 2016, 1,093 asymptomatic subjects 
aged ≥50 years, who participated in the NCSP, were invited to 
complete a questionnaire. The survey items were designed to 
investigate the patient’s preferences regarding FIT versus colo-
noscopy as a primary CRC screening method. The questionnaire 
included questions about sex, age, education, marital status, 
religion, occupation, income level, drinking, smoking, comor-
bid disease, history of colectomy, family history of CRC in ≥ 
first-degree relatives at any age, knowledge of CRC warning 
symptoms, previous participation in the NCSP, previous experi-
ence with FIT or colonoscopy, and preference as well as reason 
for the preference of FIT or colonoscopy as the primary CRC 
screening test. Comorbid disease included hypertension, type II 
diabetes mellitus, cardiovascular disease, chronic renal disease, 
cerebrovascular disease or any malignancy. Respondents who 
did not complete the questionnaire were excluded from the 
analysis. All responses were anonymous, and all respondents 
voluntary participated. This study was approved by the Institu-
tional Review Board of Kyung Hee University Hospital at Gang-
dong (KHNMC IRB number: 2016-05-027).
2. Questionnaires for preference
The questionnaire regarding primary CRC screening test 
preference was designed to elicit the patient’s preference for the 
primary CRC screening method and the reasons therein. Patients 
were asked which screening strategy they would prefer, if given 
a choice in the future (Supplementary Material 1). The question-
naire asked patients about (1) experience with and opinions 
about the NCSP; and (2) preference and reason for the prefer-
ence of a particular primary CRC screening test. The question-
naire was based on a literature review19-21 and semi-structured 
discussions with the “Committee of Endoscopy Quality Improve-
ment in the Korean Society of Gastrointestinal Endoscopy.” To 
help participants choose an appropriate primary CRC screening 
test, an information sheet was provided to participants with reli-
able, accurate, and unbiased information about the advantages 
and disadvantages of FIT versus colonoscopy to enable patients 
to answer the study questionnaire as accurately and reliably as 
possible. The questionnaire was confirmed as reliable and valid 
by four gastroenterology fellows who were not involved in 
this study, and answers from this group were used to revise the 
survey questionnaire. Reported completion times were 10 to 15 
minutes. The questions were dichotomous (yes/no) or multiple 
choice.
Table 1. Respondents’ Demographic Characteristics and Baseline Clinical Information According to the Preferred CRC Screening Method Preference
Clinical data Preference for FIT (n=124) Preference for colonoscopy (n=272) p-value
Age, yr 66.17±8.09 63.17±7.25 0.208
Male sex  39 (31.5) 100 (36.8) 0.304
Past/current smoker  14 (11.4)  42 (15.5) 0.278
Alcohol drinking  19 (15.4)  70 (25.8) 0.022
Education (university or above)  29 (23.8)  91 (34.9) 0.029
Marital status (married) 113 (91.1) 252 (93.3) 0.436
Religion (yes)  84 (67.7) 175 (64.3) 0.509
Employment 0.139
    Full-/part-time  33 (26.6)  92 (34.1)
    Not working/homemaker  91 (73.4) 178 (65.9)
Income (dollars/mo) 0.013
    <1,818  75 (65.2) 141 (54.2)
    1,818–4,545  37 (32.2)  90 (34.6)
    >4,545  3 (2.6)  29 (11.2)
Comorbid disease (yes)  63 (50.8) 126 (46.3) 0.408
Previous colectomy (yes)  2 (1.6) 17 (6.3) 0.043
Family history of CRC  6 (4.8)  33 (12.2) 0.023
Acquaintances with CRC (yes)  18 (14.6)  71 (26.1) 0.012
Data are presented as mean±SD or number (%).
CRC, colorectal cancer; FIT, fecal immunochemical test.
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Table 2. Factors Influencing Patients’ Preference for a CRC Screening Method
Variable
OR (95% CI)
FIT preference Colonoscopy preference p-value
Age group, yr 0.001
    50–59 Reference Reference
    60–69 1.582 (0.926–2.703) 0.632 (0.370–1.080) 0.094
    ≥70 3.037 (1.671–5.519) 0.329 (0.181–0.598) <0.001
Sex 
    Male Reference Reference
    Female 1.267 (0.806–1.992) 0.789 (0.502–1.240) 0.305
Smoker 
    No Reference Reference
    Yes 0.700 (0.367–1.337) 1.428 (0.748–2.726) 0.280
Alcohol drinking 
    No Reference Reference
    Yes 0.525 (0.300–0.918) 1.906 (1.089–3.336) 0.024
Education 
    High school or less Reference Reference
    University or more 0.583 (0.357–0.949) 1.717 (1.053–2.798) 0.030
Marital status 
    Married Reference Reference
    Unmarried 0.734 (0.336–1.604) 1.363 (0.623–2.980) 0.438
Religion 
    No Reference Reference
    Yes 1.164 (0.742–1.827) 0.859 (0.547–1.349) 0.509
Full-/part-time employment 
    No Reference Reference
    Yes 1.425 (0.890–2.283) 0.702 (0.438–1.124) 0.140
Income (dollars/mo) 0.025
    <1,818 Reference Reference
    1,818–4,545 0.773 (0.481–1.242) 1.294 (0.805–2.079) 0.287
    >4,545 0.194 (0.057–0.660) 5.142 (1.516–17.438) 0.009
Comorbid disease 
    No Reference Reference
    Yes 1.197 (0.782–1.831) 0.836 (0.546–1.278) 0.408
Previous colectomy 
    No Reference Reference
    Yes 0.243 (0.055–1.069) 4.115 (0.936–18.096) 0.061
Family history of CRC 
    No Reference Reference
    Yes 0.367 (0.149–0.900) 2.727 (1.112–6.690) 0.028
Acquaintances with CRC
    No Reference Reference
    Yes 0.485 (0.275–0.857) 2.061 (1.167–3.638) 0.013
CRC, colorectal cancer; OR, odds ratio; CI, confidence interval; FIT, fecal immunochemical test.
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3. Statistical analysis
For the sample size estimation, we assumed that the 2-fold 
difference in the preference for CRC screening tools between 
colonoscopy and FIT would be sufficient for clinicians to rec-
ommend colonoscopy rather than FIT as a primary screening 
test. Based on these assumptions and 26.6% FIT participation 
rate of NCSP, 2014 in Korea, a minimum of 51 subjects were re-
quired for a power of 80% to detect a difference at p<0.05 level 
of significance.
Categorical variables are expressed as numbers (percentage), 
whereas continuous variables are expressed as mean±standard 
deviation. Factors influencing preference for CRC screening tests 
were evaluated using binary logistic regression with odds ratios 
and a 95% confidence interval. Two-tailed p-values <0.05 were 
considered statistically significant. Statistical analyses were 
performed using the SPSS version 18.0 for Windows (SPSS Inc., 
Chicago, IL, USA).
RESULTS
Among 1,093 asymptomatic subjects aged ≥50 years who 
participated in the NCSP in our hospital, 414 answered this 
survey for a response rate of 37.9%. Overall, the survey results 
from 396 respondents were analyzed after the exclusion of 16 
surveys because of incomplete answers (n=4), duplicate answers 
(n=2), participant age <50 (n=4), or no preferred primary screen-
ing (n=8). The complete overall response rate was 36.2%. 
1. Characteristics of the survey respondents
The respondents included 139 men (35.1%) and 257 women 
(64.9%) with a mean age of 64.1±7.6 years. Table 1 shows the 
demographic characteristics and baseline clinical information 
of the respondents by CRC screening method preference: FIT 
preference group versus colonoscopy preference group. In this 
study, colonoscopy was preferred to FIT at a ratio of 2.2 to 1 
(68.7% vs 31.3%) as a primary CRC screening test in the NCSP. 
There was no intergroup difference in age or sex distribution. 
However, alcohol drinkers as well as participants with a higher 
education or income level, a previous colectomy history, a fam-
ily history of CRC, or acquaintances with CRC preferred colo-
noscopy.
2. Factors influencing screening method preference and 
reasons 
Elderly participants significantly preferred the FIT (p<0.001) 
with an age-dependent correlation (Table 2). However, sex did 
not influence preference. In contrast, participants who were 
alcohol drinkers (p=0.024), had a higher education (p=0.030) or 
income level (p=0.025), had a family history of CRC (p=0.028), 
or had acquaintances with CRC (p=0.013) preferred colonos-
copy. For the patients’ preferences in Table 3, FIT was preferred 
for its convenience and simplicity (72.8%) as well as low cost 
(4.8%). In contrast, colonoscopy was preferred for its accuracy 
(79.4%) and ability to provide therapeutic options (15.8%). 
3. Experience with and opinions about the NCSP
More than 90% of participants frequently participated in the 
NCSP (Table 4). Only 12.9% of participants had a bad experi-
ence with FIT, the major reasons for which were stool sampling 
(77.8%), and storage and transportation (20.0%). Conversely, 
39.3% of participants had a bad experience with colonoscopy, 
primarily due to bowel preparation (68.9%) and the complicated 
examination process itself (25.5%).
DISCUSSION
Primary colonoscopy screening may be superior consider-
ing its ability to remove the adenomatous polyp,22 although FIT 
is a more efficient CRC screening method.4,23 Choices for CRC 
screening options differ among countries.2-4 Although some 
Western countries provide primary colonoscopy screening,7 its 
adoption should be based on patient preference about screening 
methods, socioeconomic considerations, the current capacity to 
perform colonoscopy in each country, and its efficacy at pre-
venting CRC. The planning of a primary colonoscopy screening 
strategy in Korea should be based on NCSP participant prefer-
ence data. Our results indicate that colonoscopy was preferred 
to FIT at a ratio of 2.2 to 1 (68.7% vs 31.3%) as a primary CRC 
screening test by NCSP participants. Our study showed that 
elderly participants preferred FIT, whereas participants with 
higher education and income levels as well as those with fam-
ily members or acquaintances with CRC preferred colonoscopy. 
The current study is the first to evaluate primary CRC screening 
method preferences in NCSP participants. 
Four large randomized controlled trials are currently evalu-
Table 3. Reasons Why Patients Prefer the FIT versus Colonoscopy
Reason for choosing Percent
FIT
    FIT is convenient and simple 72.8
    FIT is safe 2.4
    FIT is inexpensive 4.8
    Colonoscopy is too complicated a process 12.8
    Other 7.2
Colonoscopy
    Colonoscopy is accurate 79.4
    Colonoscopy can provide therapeutic options 15.8
    FIT is inconvenient 1.5
    Colonoscopy is convenient 1.5
    Other 1.8
FIT, fecal immunochemical test.
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ating the completion rate of a primary colonoscopy screening 
program,24-27 and the long-term results are expected in the next 
decade. In a randomized controlled trial comparing primary 
colonoscopy with biannual FIT in Spain, the participation rate 
was higher in FIT group than in colonoscopy group (34.2% vs 
24.6%, p<0.001).24 The different participation rates resulted in 
the same CRC detection rate in both groups. In a recent German 
population–based case-control study,28 only 1.7% of the pa-
tients with CRC underwent screening colonoscopy versus 12% 
of the patients without CRC. In a meta-analysis of prospective 
CRC screening studies,29 the overall participation rates for FIT 
and colonoscopy were 42% and 28%, respectively. In the United 
States, participation rates were higher for FIT group than colo-
noscopy group (58.8% vs 42.4%, respectively, p<0.001).23 Our 
study result contrasted those of previous studies23,24,29,30 in that 
colonoscopy was preferred to FIT; however, our findings may 
be cautiously interpreted as socioeconomic status, the capacity 
to perform colonoscopy, and perceived awareness of CRC may 
differ among countries. In Korea, the excellent accessibility and 
low cost of colonoscopy, and the availability of experienced 
colonoscopists may have influenced our results of a higher pref-
erence for colonoscopy. However, sufficient information should 
be provided to participants about the advantages and disadvan-
tages of FIT versus colonoscopy to enable their informed deci-
sions, as their choice may change after education. For example, 
in a CRC screening from Hong Kong,19 patients initially chose 
colonoscopy over FIT (47.4% vs 21.8%, respectively); however, 
27.1% of participants changed to FIT from colonoscopy and 
8% changed to colonoscopy from FIT after the educational ses-
sion. As a result, the final participation rate was higher in the 
FIT group than in the colonoscopy group (61% vs 39%, respec-
tively). 
Considering the lower participation rate of CRC screening 
than those for other cancers,7-9 strategies to increase participa-
tion rates are needed. Accordingly, the choice of screening 
modality may encourage individuals to participate, as we noted 
substantial variation in CRC screening method preference by 
age, family history of CRC, and socioeconomic status. Further-
more, a detailed information system, such as interviews, an 
online system, or leaflets should be provided to increase the 
participation rate through their informed decisions. Consider-
ing that only 12.9% of participants reported a previous bad 
experience with FIT and 39.3% experienced a bad experience 
with colonoscopy, sufficient information about the advantages 
and disadvantages of FIT and colonoscopy may be essential to 
increasing CRC screening participation rates. In a multi-criteria 
decision analysis, inconvenience, safety, and testing frequency 
were most significantly associated with intention to attend.30
This study had some limitations. First is the possibility of 
selection bias derived from its single-center design. In addi-
tion, there is likely some sampling bias in the participants since 
the complete overall response rate was only 36.2% and that all 
respondents are thought to be interested in the NCSP. Second, 
our study was based on a questionnaire rather than actual data 
from administrative or clinical trials. As demonstrated in a 
CRC screening program of Hong Kong,19 a significant number 
of participants may change their initial opinion just before the 
actual CRC screening tests are performed. Therefore, an actual 
clinical trial on this issue is warranted in the future. However, 
this kind of study may incur large economic and resource bur-
dens. Third, this survey tool was not verified for the reliability 
and validity. However, members of “Committee of Endoscopy 
Table 4. Respondents’ Experiences with and Opinions about the NCSP
Opinion No. (%)
Experience of NCSP participation Annually–frequently 357 (90.2)
Often–infrequently  39 (9.8)
Experience of FIT participation
    Experience of FIT participation None 56 (14.1)
    Bad experience from FIT Yes 44 (12.9)
    Cause of bad experience from FIT Stool sampling 35 (77.8)
Stool storage and transportation  9 (20.0)
Other  1 (2.2)
Experience of colonoscopy participation
    Experience of colonoscopy participation None 134 (33.8)
    Bad experience with colonoscopy Yes 103 (39.3)
    Cause of bad experience from colonoscopy Complicated preparation process  73 (68.9)
Complicated colonoscopy process itself 27 (25.5)
High medical cost  3 (2.8)
Other  3 (2.8)
NCSP, National Cancer Screening Program; FIT, fecal immunochemical test.
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Quality Improvement in the Korean Society of Gastrointestinal 
Endoscopy” checked this survey tool as we failed to find any 
verified survey tools on this issue. Finally, previous history of 
colon polyp was not investigated in this study. As patients with 
experience of polypectomy may be more aware of importance 
of colon polyp removal, it would be better if they were excluded 
from this study. 
In conclusion, colonoscopy was preferred to FIT at a ratio 
of 2.2 to 1 in NCSP participants in Korea. The demonstrated 
colonoscopy preference should be considered in the creation of 
a primary colonoscopy screening strategy in Korea. However, 
actual clinical trial data about this issue are needed. 
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